Gujarat Kidney’s fresh public issue sparked noticeable interest on its first bidding day, especially from retail investors.
By the end of Day 1 (Dec 22), the issue received bids for 2.02 crore shares against an offer of 1.32 crore shares, giving an overall subscription of 1.53 times.
The company is raising ₹250.80 crore through a book‑built issue of 2.20 crore fresh shares. The price band is set at ₹108 – ₹114 per share.
As of today, the grey market premium (GMP) is around ₹7 per share, hinting at a potential listing price near ₹121 – roughly a 6% premium over the issue’s top price. While GMP can give an early sense of market sentiment, it should not be the sole basis for investment decisions.
Gujarat Kidney operates a network of mid‑size multi‑specialty hospitals in central Gujarat, focusing on secondary and tertiary care. The consolidated group runs:
The company aims to expand its footprint while delivering integrated healthcare services.
Remember, this is perspective, not a prediction. Do your own research and consult certified experts before making any investment decisions.
Download the TradeKaizen app to practice F&O trading with real-time market data anytime, anywhere.
Get it on Google PlayConnect with fellow traders, share strategies, and improve your trading skills in our Telegram group.
Join Telegram